Related Experiment Video
Updated: May 1, 2026

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells
Published on: November 26, 2018
Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic
Clara Steichen1, Eléanor Luce1, Jérôme Maluenda1
1INSERM Unité Mixte de Recherche S972, Université Paris-Sud, Unité Mixte de Recherche S972, and Département Hospitalo-Universitaire Hepatinov, Paul Brousse Hospital, Villejuif, France; INSERM Unité Mixte de Recherche S986, Institut Fédératif de Recherche 93, Bicêtre Hospital, Kremlin-Bicêtre, France; Department of Cytogenetics, INSERM U935, Béclère Hospital, Clamart, France; Centros de Investigación Biomédica en Red de Diabetes y Obesidad, Centro de Investigación Principe Felipe, Eduardo Primo Yúfera 3, Valencia, Spain; Molecular Genetics Center, Centre National de la Recherche Scientifique, Unité Propre de Recherche 3404, Gif-sur-Yvette, Université Paris-Sud, Orsay, France.
Abstract:
The use of synthetic messenger RNAs to generate human induced pluripotent stem cells (iPSCs) is particularly appealing for potential regenerative medicine applications, because it overcomes the common drawbacks of DNA-based or virus-based reprogramming strategies, including transgene integration in particular. We compared the genomic integrity of mRNA-derived iPSCs with that of retrovirus-derived iPSCs generated in strictly comparable conditions, by single-nucleotide polymorphism (SNP) and copy number variation (CNV) analyses. We showed that mRNA-derived iPSCs do not differ significantly from the parental fibroblasts in SNP analysis, whereas retrovirus-derived iPSCs do. We found that the number of CNVs seemed independent of the reprogramming method, instead appearing to be clone-dependent. Furthermore, differentiation studies indicated that mRNA-derived iPSCs differentiated efficiently into hepatoblasts and that these cells did not load additional CNVs during differentiation. The integration-free hepatoblasts that were generated constitute a new tool for the study of diseased hepatocytes derived from patients' iPSCs and their use in the context of stem cell-derived hepatocyte transplantation. Our findings also highlight the need to conduct careful studies on genome integrity for the selection of iPSC lines before using them for further applications.
More Related Videos
Related Concept Videos
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Induced Pluripotent Stem Cells
Somatic...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

